Literature DB >> 23024965

Fibromyalgia dyscognition: concepts and issues.

K R Ambrose1, R H Gracely, J M Glass.   

Abstract

Fibromyalgia is characterized by widespread pain and tenderness; however, comorbid cognitive difficulties are a common complaint among patients. Known as fibro fog or dyscognition, this symptom comprises difficulties with complex cognitive processes including memory, executive function, concentration and attention. While the mechanisms that initiate and maintain these cognitive deficits are still largely unknown, recent research has increased the understanding of subjective symptoms and objectively-determined deficits in cognitive performance. Treatments have also improved to include complementary cognitive and physical strategies. This review focuses on issues of dyscognition in fibromyalgia. Details of objective testing methods are not within the scope of this paper.

Entities:  

Mesh:

Year:  2012        PMID: 23024965     DOI: 10.4081/reumatismo.2012.206

Source DB:  PubMed          Journal:  Reumatismo        ISSN: 0048-7449


  15 in total

Review 1.  Fibrofog and fibromyalgia: a narrative review and implications for clinical practice.

Authors:  Howard M Kravitz; Robert S Katz
Journal:  Rheumatol Int       Date:  2015-01-13       Impact factor: 2.631

2.  Disrupted brain circuitry for pain-related reward/punishment in fibromyalgia.

Authors:  Marco L Loggia; Chantal Berna; Jieun Kim; Christine M Cahalan; Randy L Gollub; Ajay D Wasan; Richard E Harris; Robert R Edwards; Vitaly Napadow
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

Review 3.  Neuroimaging of Central Sensitivity Syndromes: Key Insights from the Scientific Literature.

Authors:  Brian Walitt; Marta Ceko; John L Gracely; Richard H Gracely
Journal:  Curr Rheumatol Rev       Date:  2016

4.  Working memory dysfunction in fibromyalgia is associated with genotypes of the catechol- O-methyltransferase gene: an event-related potential study.

Authors:  David Ferrera; Francisco Gómez-Esquer; Irene Peláez; Paloma Barjola; Roberto Fernandes-Magalhaes; Alberto Carpio; María Eugenia De Lahoz; María Carmen Martín-Buro; Francisco Mercado
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-13       Impact factor: 5.760

Review 5.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

6.  Do cognitive and physical fatigue tasks enhance pain, cognitive fatigue, and physical fatigue in people with fibromyalgia?

Authors:  Dana L Dailey; Valerie J Keffala; Kathleen A Sluka
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-02       Impact factor: 4.794

7.  Assessing Cognitive and Psychomotor Performance in Patients with Fibromyalgia Syndrome.

Authors:  Sergey Shmygalev; Oguzhan Dagtekin; Hans Jürgen Gerbershagen; Hanke Marcus; Martin Jübner; Rainer Sabatowski; Frank Petzke
Journal:  Pain Ther       Date:  2014-10-25

8.  Fibromyalgia patients have reduced hippocampal volume compared with healthy controls.

Authors:  Christina S McCrae; Andrew M O'Shea; Jeff Boissoneault; Karlyn E Vatthauer; Michael E Robinson; Roland Staud; William M Perlstein; Jason G Craggs
Journal:  J Pain Res       Date:  2015-01-30       Impact factor: 3.133

9.  Characterizing "fibrofog": Subjective appraisal, objective performance, and task-related brain activity during a working memory task.

Authors:  Brian Walitt; Marta Čeko; Manish Khatiwada; John L Gracely; Rakib Rayhan; John W VanMeter; Richard H Gracely
Journal:  Neuroimage Clin       Date:  2016-02-02       Impact factor: 4.881

10.  Identifying the symptom and functional domains in patients with fibromyalgia: results of a cross-sectional Internet-based survey in Italy.

Authors:  Fausto Salaffi; Flavio Mozzani; Antonella Draghessi; Fabiola Atzeni; Rosita Catellani; Alessandro Ciapetti; Marco Di Carlo; Piercarlo Sarzi-Puttini
Journal:  J Pain Res       Date:  2016-05-13       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.